Oxford University Press

SHERPA: Yellow

People

  1. Aghajanian
    Aghajanian
  2. Makker
    Makker
  3. Weigelt
    Weigelt
  4. Selenica
    Selenica
  5. Norton
    Norton
  6. O'Cearbhaill
    O'Cearbhaill
  7. Friedman
    Friedman
  8. Konner
    Konner
  9. Mandelker
    Mandelker
  10. Pareja Zea
    Pareja Zea

Groups

  1. Gynecology Disease Management Team (147)
  2. Solid Tumor Oncology Division (116)
  3. Department of Medicine (115)
  4. GDMT, Medicine (101)
  5. Gynecologic Medicine Service (93)
  6. GDMT, Pathology and Laboratory Medicine (39)
  7. GSK Faculty (34)
  8. Human Oncology and Pathogenesis Program (32)
  9. Surgery (28)
  10. Survivorship Research (25)
Search Within
  1. "Gynecology Disease Management Team "
Formats
  1. Meeting Abstract (86)
  2. Journal Article (55)
  3. Book Section (3)
  4. Guidelines (2)
  5. Editorial (1)
Groups
  1. Gynecology Disease Management Team (147)
  2. Solid Tumor Oncology Division (116)
  3. Department of Medicine (115)
  4. GDMT, Medicine (101)
  5. Gynecologic Medicine Service (93)
  6. GDMT, Pathology and Laboratory Medicine (39)

More Groups

People
  1. Carol Aghajanian (29)
  2. Britta Weigelt (24)
  3. Jorge Reis-Filho (22)
  4. Vicky Makker (20)
  5. Pier Selenica (13)
  6. Larry Norton (11)

More People

Years
  1. 2024 (2)
  2. 2023 (20)
  3. 2022 (25)
  4. 2021 (20)
  5. 2020 (9)
  6. 2019 (18)

More Years

Publications
  1. Annals of Oncology (107)
  2. JNCI: Journal of the National Cancer Institute (27)
  3. American Journal of Clinical Pathology (3)
  4. Journal of the National Cancer Institute - Monographs (2)
  5. Handbook of Communication in Oncology and Palliative Care (1)
  6. Human Molecular Genetics (1)

More Publications

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Application of three-dimensional imaging software to map carcinomatosis in recurrent ovarian cancer
    Journal Article

    da Costa, A. G.; Albergaria, D.; Almeida, J.; Nave, M.; Oliveira, J.; Catarino, A.; Chi, D. S.; Casanova, J.
    Journal of Surgical Case Reports (2024)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study
    Meeting Abstract

    Oh, D. Y.; Meric-Bernstam, F.; Makker, V.; Oaknin, A.; Banerjee, S.; Gonzalez Martin, A.; Jung, K. H.; Lugowska, I.; Manso, L. M.; Manzano, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Stadler, Z.; Yaeger, R.; Smith, J. J.; Saltz, L.; Widmar, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Updated response data and analysis of progression free survival by mechanism of mismatch repair loss in endometrial cancer (EC) patients (pts) treated with pembrolizumab plus carboplatin/ paclitaxel (CP) as compared to CP plus placebo (PBO) in the NRG GY018 trial
    Meeting Abstract

    Eskander, R. N.; Sill, M.; Miller, A.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M. S.; Canturia, G.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival (OS) outcomes from NRG-GY004, a phase III study comparing single-agent olaparib or combination cediranib and olaparib to platinum (Plat) based chemotherapy in recurrent plat sensitive ovarian cancer (OvCa)
    Meeting Abstract

    Liu, J. F.; Brady, M.; Matulonis, U. A.; Miller, A.; Kohn, E. C.; Swisher, E.; Tew, W.; Cloven, N.; Muller, C.; Bender, D.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study
    Meeting Abstract

    Meric-Bernstam, F.; Makker, V.; Oaknin, A.; Oh, D. Y.; Banerjee, S.; Gonzalez Martin, A.; Jung, K. H.; Lugowska, I.; Manso, L. M.; Manzano, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Novel therapeutic opportunities in metaplastic breast cancer
    Meeting Abstract

    Pareja, F.; Gazzo, A.; Dopeso, H.; Brown, D.; Selenica, P.; Zhu, Y.; Blanco Heredia, J.; Gusain, L.; Pei, X.; Marra, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Alternative molecular mechanisms underpinning breast invasive lobular carcinoma identified by genomics-driven artificial intelligence model
    Meeting Abstract

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A.; Brown, D.; Selenica, P.; Bernhard, J.; Sue, J.; Lee, M. C. H.; Godrich, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • APOBEC mutagenesis and macrophage infiltration in cancer
    Meeting Abstract

    Gazzo, A.; Marra, A.; Zhu, Y.; Gupta, A.; Selenica, P.; Pei, X.; Weigelt, B.; Pareja, F.; Riaz, N.; Reis, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save